
27 Aug 2020 Governance
Leukaemia UK appoints new CEO
The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, helping lead two mergers to create the UK’s largest breast cancer charity, as well as critical policy and campaigning successes, in her role as Director of Communications, Engagement & Influencing at Breast Cancer Now since 2014.
Chris Corbin OBE, Chairman of Leukaemia UK Trustees and a Director of Corbin & King, said:
“We are thrilled to welcome Fiona as our new CEO. Fiona brings a wealth of experience in the cancer charity sector and has outstanding leadership qualities. We are confident Fiona will lead Leukaemia UK to make an even more significant impact to those affected by leukaemia and other blood cancers. With blood cancer being the 5th most common type of cancer in the UK, it is essential that we continue to deliver on our objective to fund more vital research and care, especially during these unprecedented times. We look forward to having Fiona at the helm of Leukaemia UK to help deliver this mission.”
Fiona Hazell said:
“I’m hugely excited to be joining the Leukaemia UK team as CEO to drive progress for all those affected by leukaemia and other blood cancers – the UK’s third biggest cancer killer. Now more than ever, blood cancer patients and their families across the UK, need new hope for the future and greater support day-to-day and I look forward to collaborating with our incredible supporters and the wider blood cancer community to meet that challenge.”
Fiona begins on 9th September 2020.
Please do not hesitate to contact us on contribute@leukaemiauk.org.uk if you have any questions or queries.
Find out more about our ground-breaking research and care projects.
September is Blood Cancer Awareness Month, find out ways you can get involved.
Related posts
19 June 2023
Leukaemia UK research paves the way for personalised lymphoma treatment
Despite promising trials, standard treatment for diffuse large B-cell lymphoma (DLBCL) hasn’t changed in a decade. New treatment strategies for this type of blood cancer are urgently needed. Could the…
16 November 2021
John Goldman Fellowships for 2022 open in December
Leukaemia UK is delighted to continue its investment and funding for early career scientists and clinicians in 2022.
1 August 2022
One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan
Today, with over 50 cancer charities, we wrote to the Secretary of State for Health & Social Care, Sajid Javid, to set out our expectation for next month’s 10-Year Cancer Plan….
7 November 2024
University of Southampton’s Dr Giorgia Chiodin Wins Olive Boles Innovation Award
Dr Giorgia Chiodin from the University of Southampton has been awarded the prestigious Olive Boles Innovation Award for 2024. Awarded annually to a Leukaemia UK John Goldman Fellow, this award…